Eli Lilly and Company

Sr. Director - Global Diagnostics Partnerships

Chester, Maryland, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Position Overview

  • Location Type: Not Specified
  • Job Type: Full time
  • Salary: Not Specified

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Organization Overview: At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you also can count on us to develop creative solutions to support communities through philanthropy and volunteerism.

Role Overview: The Sr. Director, Global Diagnostics Partnerships will leverage their deep diagnostic partnering knowledge to create clear strategic plans for innovative partnerships for Lilly to advance patient identification goals. In addition, this incumbent will provide expertise across business units in a rapidly evolving global diagnostic partnership ecosystem to support key markets in initiative creation and prioritization, supporting innovation and launch readiness for biomarker-directed medicines.

Responsibilities

  • Deliver strategic guidance to cross-functional partners and business units as the global central expert on diagnostic partners (e.g., lab & kit providers).
  • Identify and create new opportunities for partnerships in order to advance Lilly’s patient identification goals across therapeutic areas.
  • Own and cultivate relationships with key US & OUS national reference labs and diagnostic providers and facilitate leadership exchanges between companies, as appropriate.
  • Develop novel partnership models and shared learnings internally to improve our innovation and launch readiness across business units.
  • Develop and support the execution of lab/IVD partnership strategies.
  • Define new and simplified internal processes to enhance alignment with global diagnostic strategy and Lilly processes (i.e. commercial collaboration agreements, statements of work, etc.).
  • Oversee global partnerships and ensure compliance and effectiveness.
  • Function as the “face of Lilly” to global diagnostic partners on behalf of commercialization teams.
  • Support sourcing, strategic alignment on acquisition, (with commercial, legal, compliance, business insights and analytics etc.), and ongoing impact measurement of diagnostic data purchases.
  • Maintain up-to-date knowledge of the rapidly evolving precision medicine and diagnostic partnership landscape.

Minimum Qualifications

  • Bachelor’s Degree
  • Minimum of 4 years relevant experience working in Business Development and/or partnership function within diagnostics industry.
  • Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization and/or visas for this role.

Preferred Qualifications

  • 6+ years relevant diagnostic partnership experience.
  • Advanced degree (e.g. Ph.D. or MS/MBA).
  • Deep understanding of, and strong network within, diagnostic ecosystem.
  • Strong ability to network across the diagnostic industry.

Additional Skills and Preferences

  • Outcomes Focus: Demonstrated both a bias for action and focus on results.
  • Problem Solving: Demonstrated ability to appropriately diagnose business problems and create and implement appropriate solutions.
  • Measurement Orientation: Demonstrated ability and propensity to use data, measurement and analytics to diagnose problems and to evaluate the actual effect of changes implemented.
  • Deep curiosity and drive to solve complex problems and create impactful solutions.
  • Teamwork orientation, interpersonal astuteness, and able to work with others.

Skills

diagnostic partnerships
strategic planning
biomarker development
collaborative relationship management
global healthcare

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI